No Data
No Data
List of convertible stocks (Part 1) [List of Parabolic Signal convertible stocks]
○ List of stocks that have shifted to Buy Market Code Stock Name Closing Price SAR Main Board <1301> Kyokuyo 4085 3615 <1417> Mirait One 21001860 <1433> Bestella 1037882 <1518> Mitsui Matsushima HD 38853275 <167A> Ryosan Ryo 23002035 <1801> Taisei Corporation 66275793 <1808> Haseko Corporation 19521788 <1
NTT, Japan CMK, etc.
Tsuruha HD <3391> will merge with Welcia in December, creating an alliance with a revenue of 2 trillion yen.
Marudai Foods has updated its high price [new high and new low stock update].
The stocks that updated new highs on the Main Board are Meiji Holdings <2269> and Marudai Food <2288>, totaling 42 stocks. The stocks that updated new lows on the Main Board are ZOZO <3092> and ABC Mart <2670>, totaling 6 stocks. "Main Board" "Standard Board" "Growth Board" New Highs New Lows New Highs New Lows New Highs New Lows 04/11 422 327 151 050 4/10 436 255 810 4/09 910 846 233 704/08 10 51
BakerCurrent and others continue to rank, with operating profit expected to increase by 24% from the previous period and 19% this period, along with some changes to the basic policy on shareholder returns.
Baikalent <6532> has ranked in (as of 4:11 PM). Significant continued rise. After the previous day's trading ended, it announced its financial results for the fiscal year ending in February 2025. The operating profit is 42.6 billion yen (an increase of 24.5% compared to the previous period). The operating profit for the fiscal year ending in February 2026 is estimated to be 51 billion yen (an increase of 19.7% compared to the previous period). At the same time, it announced a partial change in the basic policy for shareholder returns and a share buyback with a limit of 0.31% of issued Stocks. Top changes in Volume [As of April 11, 1:32 PM] (compared to the average Volume over the last 5 days) Code Name
April 11th [Today's Investment Strategy]
[Fisco Selected Stocks] 【Material Stocks】 Beikaren <6532> 6,757 yen (4/10) provides Consulting Services. Announced financial results for the fiscal year ending February 2025. Operating profit is 42.6 billion yen (24.5% increase compared to the previous period). The operating profit for the fiscal year ending February 2026 is estimated at 51 billion yen (19.7% increase compared to the previous period). At the same time, the basic policy for shareholder returns has been partially revised, setting a dividend payout ratio at 40% on an IFRS basis, and regarding annual surplus cash, focusing on Share Buyback for shareholder returns.
Focusing on Warabe Nichiyo and Beikarebento, while Tama Home and Alenza HD appear weak.
In the U.S. stock market on the 10th, the Dow Jones Industrial Average fell by $1,014.79 to $39,593.66, the Nasdaq Composite Index dropped by 737.66 points to 16,387.31, and the Chicago Nikkei 225 Futures declined by 1,240 to ¥33,400 compared to Osaka during the day. The exchange rate is 1 dollar = 144.40-50 yen. In today's Tokyo market, Hisamitsu Pharmaceutical Co., Ltd. <4530>, which had a Financial Estimates operating profit increase of 43.5%, exceeding the previous estimate of a 36.7% increase, has an operating profit projected to increase by 24.5% for the previous period and 19.7% for the current period, leading to shareholder returns.